| Authors: |
Moliner-Cubel S; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, Spain., Bahamontes-Rosa N; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, Spain., Rodriguez-Alejandre A; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, Spain., Nassau PM; Department of Biological Sciences, GlaxoSmithKline, Stevenage, SG2 7NY, UK., Argyrou A; Department of Biological Sciences, GlaxoSmithKline, Stevenage, SG2 7NY, UK., Bhardwaja A; Department of Biological Sciences, GlaxoSmithKline, Stevenage, SG2 7NY, UK., Buxton RC; Department of Biological Sciences, GlaxoSmithKline, Stevenage, SG2 7NY, UK., Calvo-Vicente D; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, Spain., Mouzon B; Department of Biological Sciences, GlaxoSmithKline, Stevenage, SG2 7NY, UK., McDowell W; Department of Biological Sciences, GlaxoSmithKline, Stevenage, SG2 7NY, UK., Mendoza-Losana A; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, Spain., Gomez-Lorenzo MG; Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Madrid, Spain. Electronic address: maria.g.gomez@gsk.com. |
